Article
Signal peptide peptidase dependent cleavage of type II transmembrane substrates releases intracellular and extracellular signals.
European journal of pharmacology - 1 Jul 2006
Dev Kumlesh K, Chatterjee Sandipan, Osinde Maribel, Stauffer Daniela, Morgan Hannah, Kobialko Monika, Dengler Uwe, Rueeger Heinrich, Martoglio Bruno, Rovelli Giorgio
Abstract excerpt
The intramembrane-cleaving proteases (I-CLiPs) presenilin-1 and -2 (PS1 and PS2), signal peptide peptidase (SPP) and the Site-2 protease (S2P) catalyze critical steps in cell signaling and are implicated in diseases such as Alzheimer's disease, hepatitis C virus (HCV) infection and cholesterol homeostasis. Here we describe the development of a cellular assay based on cleavage of the transmembrane sequence of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
